Cas:19714-73-9 1-Cyclopropyl-3-methylbenzene manufacturer & supplier

We serve Chemical Name:1-Cyclopropyl-3-methylbenzene CAS:19714-73-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-Cyclopropyl-3-methylbenzene

Chemical Name:1-Cyclopropyl-3-methylbenzene
CAS.NO:19714-73-9
Synonyms:1-Methyl-3-cyclopropyl-benzol;m-methylcyclopropylbenzene;1-Cyclopropyl-3-methyl-benzol;3-cyclopropyltoluene;m-tolylcyclopropane;1-Cyclopropyl-3-methyl-Benzene;(3-tolyl)cyclopropane;Benzene,1-cyclopropyl-3-methyl
Molecular Formula:C10H12
Molecular Weight:132.20200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:198.2ºC at 760 mmHg
Density:N/A
Index of Refraction:1.558
PSA:
Exact Mass:132.09400
LogP:2.87240

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-Methyl-3-cyclopropyl-benzol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzene,1-cyclopropyl-3-methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3-tolyl)cyclopropane Use and application,1-Cyclopropyl-3-methyl-Benzene technical grade,usp/ep/jp grade.


Related News: These sites operate under cGMP conditions and have been inspected and approved by leading global pharmaceutical companies and regulatory authorities, including the US FDA. r-4,t-5-Dimethyl-c-6-phenyl-1,3,2-dioxathian-2,2-dioxid manufacturers Soliris, first approved for generalized myasthenia gravis (gMG) in 2017, carries a list price of about $470,000 annually. But to ICER, that cost is “well beyond typical thresholds.” Carboxylase, ribulose diphosphate (Heritiera littoralischloroplast-encoded gene rbcL large subunit fragment) suppliers Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. 4,6-Diethyl-3,7-dimethyl-1,9-dioxy-pyrido[3,2-g]quinoline-5,10-dione vendor & factory.